Chlorpheniramine + Dextromethorphan + Phenylephrine
Composition
This formulation contain combination of Chlorpheniramine, Dextromethorphan and Phenylephrine as active agents
Indications
relief of nasal congestion, cough, and associated symptoms of upper respiratory tract infections, including allergic rhinitis, sinusitis, and the common cold
Side effects
drowsiness, dizziness, dry mouth, constipation, and blurred vision
Precautions
caution in individuals with a history of cardiovascular disease, hypertension, or hyperthyroidism
Contraindications
individuals receiving monoamine oxidase inhibitors (MAOIs) or selective serotonin reuptake inhibitors
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablets, Syrup
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai